Improved Hearing Preservation Following Lower-Dose Fractionated Stereotactic Radiotherapy
Researchers at Thomas Jefferson University have found that a lower dose of fractionated stereotactic radiotherapy for acoustic neuromas results in better hearing preservation and has the same tumor local control rate as a higher dose of therapy. The study appeared online in the International Journal of Radiation Oncology*Biology*Physics. “We previously had not determined the optimal dose of fractionated stereotactic radiotherapy for acoustic neuromas,” said David W.